Trial · NCT00591578
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Treatment Phase | STARTED | Azilsartan Medoxomil 40 mg QD | 327 | |
| Double-Blind Treatment Phase | STARTED | Azilsartan Medoxomil 80 mg QD | 329 | |
| Double-Blind Treatment Phase | STARTED | Valsartan 320 mg QD | 328 | |
| Double-Blind Treatment Phase | COMPLETED | Azilsartan Medoxomil 40 mg QD | 249 | |
| Double-Blind Treatment Phase | COMPLETED | Azilsartan Medoxomil 80 mg QD | 249 | |
| Double-Blind Treatment Phase | COMPLETED | Valsartan 320 mg QD | 244 | |
| Double-Blind Treatment Phase | NOT COMPLETED | Azilsartan Medoxomil 40 mg QD | 78 | |
| Double-Blind Treatment Phase | NOT COMPLETED | Azilsartan Medoxomil 80 mg QD | 80 | |
| Double-Blind Treatment Phase | NOT COMPLETED | Valsartan 320 mg QD | 84 | |
| Open-Label Extension Phase | STARTED | Azilsartan Medoxomil 40 mg QD | 55 | |
| Open-Label Extension Phase | STARTED | Azilsartan Medoxomil 80 mg QD | 115 | |
| Open-Label Extension Phase | STARTED | Valsartan 320 mg QD | 0 | |
| Open-Label Extension Phase | COMPLETED | Azilsartan Medoxomil 40 mg QD | 49 | |
| Open-Label Extension Phase | COMPLETED | Azilsartan Medoxomil 80 mg QD | 105 | |
| Open-Label Extension Phase | COMPLETED | Valsartan 320 mg QD | 0 | |
| Open-Label Extension Phase | NOT COMPLETED | Azilsartan Medoxomil 40 mg QD | 6 | |
| Open-Label Extension Phase | NOT COMPLETED | Azilsartan Medoxomil 80 mg QD | 10 | |
| Open-Label Extension Phase | NOT COMPLETED | Valsartan 320 mg QD | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00591578/flow